Juliet Singh Net Worth & Insider Trades

Juliet Singh - CEO, Transdel Pharmaceuticals Inc

As of June 22, 2009

What is Juliet Singh's Net Worth?

The current estimated net worth of Transdel Pharmaceuticals Inc's CEO, Juliet Singh, is estimated to be about $2.74M . Juliet Singh owns about 1,954,125 units of Transdel Pharmaceuticals Inc common stock. In the last year at Transdel Pharmaceuticals Inc, Juliet Singh has sold an estimated value of $0 worth.

What is Juliet Singh's Past Insider Trading?

Juliet Singh's largest purchase order was 1,000 units , worth over $1.4K on September 30, 2008. In total, Juliet Singh has made about 3 transactions over a year of their time at Transdel Pharmaceuticals Inc. Juliet Singh usually trades in April, June and September, with the busiest year in 2008.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Juliet Singh

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Juliet Singh's' Mailing Address?

  • Mailing address is Transdel Pharmaceuticals, Inc. 4225 Executive Square, Suite 460 La Jolla CA 92037 CA

What are Transdel Pharmaceuticals Inc's Past Insider Trades?

Transdel Pharmaceuticals Inc's most recent insider trade came on September 30, 2008 by Juliet Singh who bought 1,000 units worth $1.4K . In the last 3 months, insiders at Transdel Pharmaceuticals Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in September, with the busiest year in 2008. The most active traders at the company are Anthony S Thornley, Director,  Juliet Singh, CEO,  and John T Lomoro, Chief Financial Officer .

TRANSDEL PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...